Pubblicazioni

Ratta, Raffaele; Verzoni, Elena; Pantano, Francesco; Grassi, Paolo; Martinetti, Antonia; Morelli, Daniele; Sottotetti, Elisa; Mennitto, Roberta; FucÃ , Giovanni; Prisciandaro, Michele; De Braud, Filippo G.; Santini, Daniele; Procopio, Giuseppe

Bone Health in Cancer Patients

2018 - Practical Medical Oncology Textbook

Santini, D; Ribelli, G; Simonetti, S; Iuliani, M; Pantano, F; Tonini, G

Novel Biomarkers predicting the development of bone metastasis in Early Breast Cancer

2018 - Dammacco: Oncogenomics

Iuliani, M; Manca, P; Ribelli, G; Simonetti, S; Pantano, F; Vincenzi, B; Tonini, G; Santini, D

The use of SAMe in chemotherapy-induced liver injury

2018 - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Vincenzi, B; Russo, A; Terenzio, A; Galvano, A; Santini, D; Vorini, F; Antonelli Incalzi, R; Vespasiani Gentilucci, U; Tonini, G

Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy?

2018 - EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY

De Lisi, D; De Giorgi, U; Lolli, C; Schepisi, G; Conteduca, V; Menna, C; Tonini, G; Santini, D; Farolfi, A

Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol

2018 - TUMORI

Gardini, Ac; Faloppi, L; Aprile, G; Brunetti, O; Caparello, C; Corbelli, J; Chessa, L; Bruno, D; Ercolani, G; Leonetti, A; de Stefano, G; Farella, N; Foschi, Fg; Lanzi, A; Dadduzio, V; Marisi, G; Masi, G; Negri, Fv; Pagan, F; Santini, D; Scarpi, E; Silletta, M; Silvestris, N; Tamburini, E; Tassinari, D; Vivaldi, C; Vespasiani Gentilucci, U; Zagonel, V; Calvetti, L; Cascinu, S; Frassineti, Gl; Scartozzi, M

Pharmacogenetics of androgen signaling in prostate cancer: Focus on castration resistance and predictive biomarkers of response to treatment

2018 - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Del Re, M; Crucitta, S; Restante, G; Rofi, E; Arrigoni, E; Biasco, E; Sbrana, A; Coppi, E; Galli, L; Bracarda, S; Santini, D; Danesi, R

Efficacy of anti-EGFR rechallenge in RAS and BRAF wt metastatic colorectal cancer: Clinical and translational results of the phase II CRICKET study by GONO

2018 - CANCER RESEARCH

Rossini, D; Cremolini, C; Del Re, M; Lonardi, S; Busico, A; Rofi, E; Garattini, Sk; Tamburini, E; Dell'Aquila, E; Corsi, D; Bergamo, F; Barone, C; Masi, G; Pucci, F; Cattaneo, M; Pietrantonio, F; Perrone, F; Tonini, G; Santini, D; Falcone, A

Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib

2018 - THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

Vincenzi, B; Nannini, M; Badalamenti, G; Grignani, G; Fumagalli, E; Gasperoni, S; D'Ambrosio, L; Incorvaia, L; Stellato, M; Ceruso, Ms; Napolitano, A; Valeri, S; Santini, D; Tonini, G; Casali, Pg; Dei Tos, Ap; Pantaleo, Ma

Development of a new clinical nomogram including velocity rate of disease progression to predict outcome in metastatic colorectal cancer patients treated with bevacizumab beyond progression: A subanalysis from tribe trial

2018 - ANNALS OF ONCOLOGY

Dell'Aquila, E; Pantano, F; Rossini, D; Stellato, M; Lonardi, S; Masi, G; Schirripa, M; Marmorino, F; Antoniotti, C; Murgioni, S; Tomasello, G; Ronzoni, M; Racca, P; Vincenzi, B; Allegrini, G; Urbano, F; Buonadonna, A; Banzi, M; Tonini, G; Cremolini, C; Falcone, A; Santini, D

FAP-related desmoid tumours treated with low dose chemotherapy: results from a multicentre retrospective analysis

2018 - JOURNAL OF CLINICAL ONCOLOGY

Vincenzi, B; Provenzano, S; Brunello, A; Badalamenti, G; Nannini, M; Ibrahim, T; Hohenberger, P; Gasperoni, S; Napolitano, A; Silletta, M; Vitellaro, M; Dei Tos, Ap; Santini, D; Tonini, G; Palassini, E

Cabozantinib affects osteosarcoma growth through a direct effect on tumor cells and modifications in bone microenvironment

2018 - SCIENTIFIC REPORTS

Fioramonti, M; Fausti, V; Pantano, F; Iuliani, M; Ribelli, G; Lotti, F; Pignochino, Y; Grignani, G; Santini, D; Tonini, G; Vincenzi, B

RANK expression in circulating tumor cells (CTCs): clinical utility in monitoring metastatic breast cancer patients (MBC) under denosumab treatment

2018 - CLINICAL & EXPERIMENTAL METASTASIS

Zamarchi, R; Facchinetti, A; Rossi, E; Zoccoli, A; Iuliani, M; Pantano, F; Vincenzi, B; Tonini, G; Santini, D

The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma

2018 - ANTI-CANCER DRUGS

Iacovelli, R; Rocca, Mc; Galli, L; Sabbatini, R; De Giorgi, U; Santini, D; Facchini, G; Mosca, A; Atzori, F; Zucali, P; Fornarini, G; Massari, F; Buti, S; Ricotta, R; Masini, C; Toscani, I; Biasco, E; Guida, A; Lolli, C; De Lisi, D; Rossetti, S; Terrone, C; Scartozzi, M; Miggiano, C; Pastorino, A; Bersanelli, M; Carlo-Stella, G; Pinto, C; Nobili, E; Nole, F; Tortora, G; Porta, C

Breakthrough cancer pain (BTcP) management: a review of international and national guidelines

2018 - BMJ SUPPORTIVE & PALLIATIVE CARE

Davies, An; Elsner, F; Filbet, Mj; Porta-Sales, J; Ripamonti, C; Santini, D; Webber, K

Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram

2018 - ONCOLOGY

Pietrantonio, F; Barretta, F; Fanotto, V; Park, Sh; Morano, F; Fuca, G; Niger, M; Prisciandaro, M; Silvestris, N; Bergamo, F; Fornaro, L; Bordonaro, R; Rimassa, L; Santini, D; Tomasello, G; Antonuzzo, L; Noventa, S; Avallone, A; Leone, F; Faloppi, L; Di Donato, S; de Braud, F; Lee, J; De Vita, F; Di Bartolomeo, M; Miceli, R; Aprile, G

Association among metabolic syndrome, inflammation, and survival in prostate cancer

2018 - UROLOGIC ONCOLOGY

Conteduca, V; Caffo, O; Galli, L; Maugeri, A; Scarpi, E; Maines, F; Chiuri, Ve; Lolli, C; Kinspergher, S; Schepisi, G; Santoni, M; Santini, D; Fratino, L; Burgio, Sl; Salvi, S; Menna, C; De Giorgi, U

Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma

2018 - ANTICANCER RESEARCH

Santoni, M; Piva, F; De Giorgi, U; Mosca, A; Bassos, U; Santini, D; Buti, S; Lolli, C; Terrone, C; Maruzzo, M; Iuliani, M; Bersanelli, M; Conti, A; Mazzucchelli, R; Montironi, R; Burattini, L; Berardi, R

Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy

2018 - PLOS ONE

Vitale, Mg; Scagliarini, S; Galli, L; Pignata, S; Lo Re, G; Berruti, A; Defferrari, C; Spada, M; Masini, C; Santini, D; Ciuffreda, L; Ruggeri, Em; Bengala, C; Livi, L; Fagnani, D; Bonetti, A; Giustini, L; Hamzaj, A; Procopio, G; Caserta, C; Sabbatini, R